SEC Form 4 · accession 0001349943-18-000012
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Walter Lloyd Sanders
Officer — President Myriad Oncology
Period of report
Sep 30, 2018
Accepted (ET)
Oct 2, 2018 · 9:10 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 30, 2018 | D | 629 | $46.00 | D | 36,824 | D | |
| Common Stock | Sep 30, 2018 | D | 629 | $46.00 | D | 36,195 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.